Month: February 2024

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICESOR FOR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, Feb. 01, 2024 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, announces that it has filed an amended and restated prospectus supplement for its previously announced offering of for aggregate gross proceeds of up to $2 million. Under the amended and restated prospectus supplement, the size of the offering is increased by $2 million to up to $4 million. The amended and restated prospectus supplement is on a non-brokered offering of up to 1,333,334 common share units (“Common Share Units”) at $3.00 per Common Share Unit, with each...

TORONTO, Feb. 01, 2024 (GLOBE NEWSWIRE) — Nexus Industrial REIT (“Nexus” or the “REIT”) (TSX: NXR.UN) announced today that it intends to release its financial results for the fourth quarter and year ended December 31, 2023 before the opening of the TSX on Thursday, March 14, 2023. Management of the REIT will host a conference call at 10:00 AM Eastern Standard Time on Thursday, March 14, 2024 to review the financial results and operations. To participate in the conference call, please dial 416-915-3239 or 1-800-319-4610 (toll free in Canada and the US) at least five minutes prior to the start time and ask to join the Nexus Industrial REIT conference call. A recording of the conference call will be available until April 14, 2024. To access the recording, please dial 604-674-8052 or 1-855-669-9658 (toll free in Canada...

HOUSTON, Feb. 01, 2024 (GLOBE NEWSWIRE) — Kayne Anderson Energy Infrastructure Fund, Inc. (the “Company”) (NYSE: KYN) today provided a summary unaudited statement of assets and liabilities and announced its net asset value and asset coverage ratios under the Investment Company Act of 1940 (the “1940 Act”) as of January 31, 2024. As of January 31, 2024, the Company’s net assets were $1.7 billion, and its net asset value per share was $10.25. As of January 31, 2024, the Company’s asset coverage ratio under the 1940 Act with respect to senior securities representing indebtedness was 585% and the Company’s asset coverage ratio under the 1940 Act with respect to total leverage (debt and preferred stock) was 420%.STATEMENT OF ASSETS AND LIABILITIESJANUARY 31, 2024   // (UNAUDITED)     (in millions)  Investments   $ 2,392.6    Cash...

LEXINGTON, Mass., Feb. 01, 2024 (GLOBE NEWSWIRE) — Fractyl Health (Nasdaq: GUTS), a metabolic therapeutics company focused on pioneering new approaches for the treatment of type 2 diabetes (T2D) and obesity, today announced the pricing of its initial public offering of 7,333,333 shares of common stock at a public offering price of $15.00 per share, for total gross proceeds of approximately $110.0 million, before deducting underwriting discounts and commissions and estimated offering expenses payable by Fractyl Health. All of the common stock is being offered by Fractyl Health. The offering is expected to close on February 6, 2024, subject to customary closing conditions. In addition, Fractyl Health has granted the underwriters a 30-day option to purchase up to an additional 1,099,999 shares of its common stock at the initial public...

TORTOLA, British Virgin Islands, Feb. 01, 2024 (GLOBE NEWSWIRE) — Orca Energy Group Inc. (“Orca” or the “Company” and includes PanAfrican Energy Tanzania Limited (“PAET“) and its other subsidiaries and affiliates) (TSX-V: ORC.A, ORC.B) announces the approval of its Independent Reserves Evaluation as at December 31, 2023. All currency amounts in this news release are in United States Dollars ($) unless otherwise stated. INDEPENDENT RESERVES EVALUATIONThe Company’s conventional natural gas reserves as at December 31, 2023 for the period to the end of the primary 25-year term of the production sharing agreement (the “Songo Songo PSA“) with the Tanzanian Petroleum Development Corporation (the “TPDC“) have been evaluated by independent petroleum engineering consultants...

SAN DIEGO, CA, Feb. 01, 2024 (GLOBE NEWSWIRE) — via NewMediaWire –Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB: “SIGYD”, “SIGY”), a development-stage medical technology company, disclosed today that a 1-for-40 reverse split of its common stock was implemented on January 31, 2024.  As a result of the split, the Company’s common stock will trade under the ticker symbol “SIGYD” for 20 business days and subsequently revert to trading under its historic symbol “SIGY” on February 29, 2024. The post-split CUSIP number for the Company’s common stock is 82674U205. The Company also reported 1,221,043 its common shares to be issued and outstanding at the close of trading on January 31, 2024. About Sigyn Therapeutics™ Sigyn Therapeutics is a development-stage medical technology company headquartered in San Diego, California....

– Preliminary safety and efficacy data from ongoing LUNA Phase 2 study of Ixo-vec for the treatment of wet AMD will be presented at the 47th Annual Meeting of the Macula Society, with company-sponsored webcast on Thursday, February 8, 2024 at 8:00am ET – REDWOOD CITY, Calif., Feb. 01, 2024 (GLOBE NEWSWIRE) — Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases, today announced that the company will host a webcast to review preliminary efficacy and safety data from its ongoing LUNA Phase 2 study of ixoberogene soroparvovec (Ixo-vec) for the treatment of wet age-related macular degeneration (wet AMD) on Thursday, February 8th, 2024 at 8:00am ET. The webcast will include Szilard Kiss, M.D., Professor of...

KING OF PRUSSIA, Pa., Feb. 01, 2024 (GLOBE NEWSWIRE) — Vertex, Inc. (NASDAQ:VERX), a leading global technology provider of indirect tax solutions, today announced that it will release fourth quarter 2023 financial results before the market opens on Thursday, February 29, 2023. A conference call to discuss the results will be held at 8:30 a.m. Eastern Time that same day. Those wishing to participate may do so by dialing 1-412-317-6026 approximately ten minutes prior to start time. A listen-only webcast of the call will also be available through the Company’s Investor Relations website at https://ir.vertexinc.com. A conference call replay will be available approximately one hour after the call by dialing 1-412-317-6671 and referencing passcode 10185697, or via the Company’s Investor Relations website. The replay will expire on March...